Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000243 | commitment complex | 5 | 2 |
GO:0005681 | spliceosomal complex | 3 | 4 |
GO:0005682 | U5 snRNP | 5 | 2 |
GO:0005684 | U2-type spliceosomal complex | 4 | 2 |
GO:0005685 | U1 snRNP | 5 | 2 |
GO:0005686 | U2 snRNP | 5 | 2 |
GO:0005687 | U4 snRNP | 5 | 2 |
GO:0005689 | U12-type spliceosomal complex | 4 | 2 |
GO:0005730 | nucleolus | 5 | 1 |
GO:0005829 | cytosol | 2 | 3 |
GO:0030532 | small nuclear ribonucleoprotein complex | 3 | 2 |
GO:0032991 | protein-containing complex | 1 | 10 |
GO:0034715 | pICln-Sm protein complex | 3 | 2 |
GO:0034719 | SMN-Sm protein complex | 3 | 2 |
GO:0043226 | organelle | 2 | 5 |
GO:0043228 | non-membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 5 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 1 |
GO:0071011 | precatalytic spliceosome | 4 | 2 |
GO:0071013 | catalytic step 2 spliceosome | 3 | 2 |
GO:0071024 | SL snRNP | 5 | 1 |
GO:0097525 | spliceosomal snRNP complex | 4 | 2 |
GO:0097526 | spliceosomal tri-snRNP complex | 5 | 2 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
GO:0120114 | Sm-like protein family complex | 2 | 2 |
GO:0140513 | nuclear protein-containing complex | 2 | 4 |
GO:1902494 | catalytic complex | 2 | 2 |
GO:1990904 | ribonucleoprotein complex | 2 | 10 |
GO:0005634 | nucleus | 5 | 4 |
GO:0043227 | membrane-bounded organelle | 3 | 4 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 4 |
Related structures:
AlphaFold database: A4ICT3
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 7 |
GO:0006396 | RNA processing | 6 | 7 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 7 |
GO:0006807 | nitrogen compound metabolic process | 2 | 7 |
GO:0008152 | metabolic process | 1 | 7 |
GO:0009987 | cellular process | 1 | 10 |
GO:0016070 | RNA metabolic process | 5 | 7 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 7 |
GO:0043170 | macromolecule metabolic process | 3 | 7 |
GO:0044237 | cellular metabolic process | 2 | 7 |
GO:0044238 | primary metabolic process | 2 | 7 |
GO:0046483 | heterocycle metabolic process | 3 | 7 |
GO:0071704 | organic substance metabolic process | 2 | 7 |
GO:0090304 | nucleic acid metabolic process | 4 | 7 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 7 |
GO:0000387 | spliceosomal snRNP assembly | 7 | 4 |
GO:0016043 | cellular component organization | 3 | 4 |
GO:0022607 | cellular component assembly | 4 | 4 |
GO:0022618 | ribonucleoprotein complex assembly | 6 | 4 |
GO:0043933 | protein-containing complex organization | 4 | 4 |
GO:0065003 | protein-containing complex assembly | 5 | 4 |
GO:0071826 | ribonucleoprotein complex subunit organization | 5 | 4 |
GO:0071840 | cellular component organization or biogenesis | 2 | 4 |
GO:0000375 | RNA splicing, via transesterification reactions | 8 | 1 |
GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 9 | 1 |
GO:0000380 | alternative mRNA splicing, via spliceosome | 9 | 1 |
GO:0000398 | mRNA splicing, via spliceosome | 8 | 1 |
GO:0006397 | mRNA processing | 7 | 1 |
GO:0008380 | RNA splicing | 7 | 1 |
GO:0016071 | mRNA metabolic process | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 136 | 138 | PF00675 | 0.683 |
CLV_NRD_NRD_1 | 93 | 95 | PF00675 | 0.513 |
CLV_PCSK_KEX2_1 | 93 | 95 | PF00082 | 0.534 |
CLV_PCSK_SKI1_1 | 103 | 107 | PF00082 | 0.527 |
CLV_PCSK_SKI1_1 | 76 | 80 | PF00082 | 0.337 |
DOC_CDC14_PxL_1 | 105 | 113 | PF14671 | 0.508 |
DOC_CDC14_PxL_1 | 84 | 92 | PF14671 | 0.524 |
DOC_MAPK_gen_1 | 71 | 80 | PF00069 | 0.608 |
DOC_MAPK_MEF2A_6 | 71 | 79 | PF00069 | 0.493 |
DOC_MAPK_RevD_3 | 109 | 125 | PF00069 | 0.686 |
DOC_USP7_MATH_1 | 19 | 23 | PF00917 | 0.387 |
DOC_USP7_MATH_1 | 2 | 6 | PF00917 | 0.564 |
DOC_USP7_MATH_1 | 57 | 61 | PF00917 | 0.493 |
DOC_USP7_MATH_1 | 86 | 90 | PF00917 | 0.550 |
DOC_USP7_UBL2_3 | 102 | 106 | PF12436 | 0.451 |
DOC_USP7_UBL2_3 | 125 | 129 | PF12436 | 0.697 |
DOC_USP7_UBL2_3 | 134 | 138 | PF12436 | 0.511 |
LIG_14-3-3_CanoR_1 | 23 | 27 | PF00244 | 0.455 |
LIG_14-3-3_CanoR_1 | 67 | 71 | PF00244 | 0.493 |
LIG_Actin_WH2_2 | 98 | 114 | PF00022 | 0.518 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.692 |
LIG_BRCT_BRCA1_1 | 13 | 17 | PF00533 | 0.503 |
LIG_BRCT_BRCA1_1 | 60 | 64 | PF00533 | 0.417 |
LIG_FHA_1 | 6 | 12 | PF00498 | 0.623 |
LIG_LIR_Gen_1 | 14 | 24 | PF02991 | 0.415 |
LIG_LIR_Nem_3 | 14 | 20 | PF02991 | 0.461 |
LIG_LIR_Nem_3 | 59 | 65 | PF02991 | 0.493 |
LIG_MYND_1 | 109 | 113 | PF01753 | 0.521 |
LIG_NRP_CendR_1 | 138 | 141 | PF00754 | 0.779 |
LIG_SH2_NCK_1 | 65 | 69 | PF00017 | 0.493 |
LIG_SH3_3 | 110 | 116 | PF00018 | 0.510 |
LIG_SUMO_SIM_par_1 | 76 | 83 | PF11976 | 0.456 |
LIG_UBA3_1 | 77 | 85 | PF00899 | 0.508 |
MOD_CK1_1 | 22 | 28 | PF00069 | 0.400 |
MOD_CK1_1 | 5 | 11 | PF00069 | 0.489 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.543 |
MOD_GSK3_1 | 66 | 73 | PF00069 | 0.573 |
MOD_LATS_1 | 56 | 62 | PF00433 | 0.417 |
MOD_N-GLC_1 | 5 | 10 | PF02516 | 0.496 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.764 |
MOD_NEK2_1 | 101 | 106 | PF00069 | 0.466 |
MOD_NEK2_1 | 41 | 46 | PF00069 | 0.493 |
MOD_PK_1 | 93 | 99 | PF00069 | 0.554 |
MOD_PKA_1 | 93 | 99 | PF00069 | 0.522 |
MOD_PKA_2 | 22 | 28 | PF00069 | 0.493 |
MOD_PKA_2 | 66 | 72 | PF00069 | 0.540 |
MOD_PKA_2 | 93 | 99 | PF00069 | 0.560 |
MOD_Plk_1 | 58 | 64 | PF00069 | 0.470 |
MOD_Plk_4 | 11 | 17 | PF00069 | 0.584 |
MOD_SUMO_rev_2 | 82 | 87 | PF00179 | 0.402 |
MOD_SUMO_rev_2 | 95 | 104 | PF00179 | 0.550 |
TRG_ENDOCYTIC_2 | 65 | 68 | PF00928 | 0.537 |
TRG_ER_diArg_1 | 92 | 94 | PF00400 | 0.572 |
TRG_ER_diLys_1 | 138 | 141 | PF00400 | 0.606 |
TRG_NLS_Bipartite_1 | 124 | 141 | PF00514 | 0.583 |
TRG_NLS_MonoExtC_3 | 136 | 141 | PF00514 | 0.667 |
TRG_NLS_MonoExtN_4 | 134 | 141 | PF00514 | 0.606 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A1X0P880 | Trypanosomatidae | 48% | 100% |
A0A3S5ISK5 | Trypanosoma rangeli | 41% | 100% |
A0A3S7X8L1 | Leishmania donovani | 31% | 100% |
A0A3S7XAB5 | Leishmania donovani | 99% | 100% |
A4HNR2 | Leishmania braziliensis | 80% | 100% |
A4IAF5 | Leishmania infantum | 32% | 100% |
D0A2M1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 46% | 100% |
E9ASH1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 89% | 100% |
Q4Q224 | Leishmania major | 89% | 100% |
Q4Q2F6 | Leishmania major | 31% | 100% |